There were 1,633 press releases posted in the last 24 hours and 400,502 in the last 365 days.


Please use this form to send email to PR contact of this press release:
Positive Phase 1 Results in Covid-19 Patients for Histogen, Inc. (NASDAQ: HSTO) Regenerative Medicine as well

Histogen Inc.
+1 858-526-3100


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image